European Innovation Coouncil Pathfinder
VC Fund
Brussels, Belgium
European Innovation Coouncil Pathfinder is a VC fund in Brussels focused on Energy and Medical. EIC Pathfinder Program provides grants for typically visionary scientists and entrepreneurial researchers from universities, research organizations, start-ups, high-tech SMEs, or industrial stakeholders interested in technological research and innovation.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries European Innovation Coouncil Pathfinder invests in
Stages European Innovation Coouncil Pathfinder invests in
Countries European Innovation Coouncil Pathfinder invests in
Round sizes
Round size
- Grant
- $398k–$4.3M
Investment Focus
Industry
- Energy 1 (25%)
- Medical 1 (25%)
- Nuclear 1 (25%)
- CleanTech 1 (25%)
- Simulation 1 (25%)
Stage
- Grant 3 (75%)
- Pre-Seed 1 (25%)
Country
- Croatia 1 (25%)
- Germany 1 (25%)
- Ireland 1 (25%)
- The Netherlands 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Developer of a novel magnetic plasma shaping system for fusion energy. This system uses magnetic fields to enhance plasma flow, control density, and reduce turbulence in magnetic confinement fusion reactors. The technology aims to improve energy confinement and stability, potentially leading to more efficient and sustainable fusion powergeneration. The approach involves modular, toroidally distributed magnetic constriction zones that modulate internal plasma dynamics without direct material contact, preserving reactor integrity. Development includes linear and partial-loop testbeds, simulation-aided refinement, and eventual integration into toroidal configurations.To solve challengesOur Next Step: Building a Strategic Consortium for EIC Pathfinder OpenWe are excited to announce our next major milestone — participation in the EIC Pathfinder Open programme 2026. This prestigious EU funding initiative supports bold, high-risk, high-reward research and innovation projects, with funding up to €4 million. We have already formed the minimum eligible consortium to enter the programme. However, to maximize our chances of success and impact, we are now focused on bringing in strategic partners who share our vision and can strengthen our interdisciplinary approach.DESC & VMEC++ Simulation Results Ready for ReviewFocus on a “Good Pre-Demo Regime”Our near-term goal is to identify and validate a credible pre-demonstration operating regime. The reference scale is a mid-size stellarator with a major radius of a few meters, comparable to W7-X. If fully three-dimensional modeling can demonstrate such a regime without extreme engineering assumptions—such as unrealistically high localized RF power—that result alone would represent a significant and credible milestone. From this foundation, a clear scaling path can be defined: moderate increases in device size and magnetic field, combined with ~2× improved confinement, provide a defensible route toward demonstration-relevant performance. We don’t offer this as a replacement for the standard MHD/transport framework, but rather as a local module; the hypothesis is that it expands the operational window, and the goal is to quantify the gains and risks through step-by-step validation.Operational WindowWe don’t offer this as a replacement for the standard MHD/transport framework, but rather as a local module; the hypothesis is that it expands the operational window, and the goal is to quantify the gains and risks through step-by-step validation. | Pre-Seed / May 21, 2025 | ||
| Smart Reactors is to promote leading-edge biomaterials technological advancements, which include biocompatible coating technology to support the long-term performance of blood-contacting devices. | $3.3M / Grant / Jan 29, 2024 | ||
| MAGNOTHERM® is an emerging university spin-off from Technische Universität Darmstadt with world leading expertise in permanent magnets and magnetic cooling.Our technology, based on solid state materials and water, is capable of replacing standard gas compression cooling or heating solutions in compliance with current and future f-gase regulationstandards.Our developed cutting-edge energy conversion solutions allow cooling and heating with low pressure systems and is 40% more efficient than current systems. At the same time it complies with all current and future EU F-gas regulations, is explosion free and non-imflammable. It is efficiently scalable in all sizes for thermal energy conversion units in decentralized, mid-range powered applications.With our clean refrigeration technology, we are able to meet the world’s fast growing demand of clean and sustainable cooling and heating applications. | $398.1K / Grant / Sep 01, 2022 | ||
| MIDA Biotech (“MIDA”) is an innovative company in the field of stem cell therapy that focuses on research and development in the field of stem cells for aging disorders, injuries, and degenerative diseases. MIDA is creating facilities to support other biotech companies through innovation in manufacturing technologies | $4.3M / Grant / Apr 07, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does European Innovation Coouncil Pathfinder invest in?
European Innovation Coouncil Pathfinder invests primarily in Energy, Medical and Nuclear startups, most often at Grant and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Croatia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does European Innovation Coouncil Pathfinder invest in?
European Innovation Coouncil Pathfinder typically joins rounds of $398k–$4.3M at Grant. These are whole funding-round sizes, not European Innovation Coouncil Pathfinder's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds European Innovation Coouncil Pathfinder took part in.
When did European Innovation Coouncil Pathfinder last invest?
The most recent investment recorded for European Innovation Coouncil Pathfinder closed in May 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
